Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach

The major obstacle in the clinical use of the antitumor drug cisplatin is inherent and acquired resistance. Typically, cisplatin resistance is not restricted to a single mechanism demanding for a systems pharmacology approach to understand a whole cell’s reaction to the drug. In this study, the cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarin, Navin, Engel, Florian, Rothweiler, Florian, Cinatl, Jindrich, Michaelis, Martin, Frötschl, Roland, Fröhlich, Holger, Kalayda, Ganna V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877628/
https://www.ncbi.nlm.nih.gov/pubmed/29518977
http://dx.doi.org/10.3390/ijms19030767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877628/
https://www.ncbi.nlm.nih.gov/pubmed/29518977
http://dx.doi.org/10.3390/ijms19030767

Ejemplares similares